TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer
Clinical trial NCT07377526 · SUSPENDED
Trial details
- NCT number
- NCT07377526
- Sponsor
- M.D. Anderson Cancer Center
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-26
- Primary completion
- 2028-03-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.